L-694,247: a potent 5-HT1D receptor agonist-Reference-Cited by-同舟云学术

L-694,247: a potent 5-HT1D receptor agonist

Published:1993-11 Issue:3 Volume:110 Page:1196-1200
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Beer M.S.,Stanton J.A.,Bevan Y.,Heald A.,Reeve A.J.,Street L.J.,Matassa V.G.,Hargreaves R.J.,Middlemiss D.N.

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.1993.tb13941.x/fullpdf

Reference24 articles.

1. Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylyl cyclase;ADHAM;Proc. Natl. Acad. Sci. U.S.A.,1993

2. Isolation of a mouse ‘5-HT1E-like’ serotonin receptor expressed predominantly in the hippocampus;AMLAIKY;J. Biol. Chem.,1992

3. An investigation of the 5-HT1D receptor binding affinity of 5-hydroxytryptamine, 5-carboxyamidotryptamine and sumatriptan in the central nervous system of seven species;BEER;Eur. J. Pharmacol.,1992

4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding;BRADFORD;Anal. Biochem.,1976

5. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H]-ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor;BRANCHEK;Mol. Pharmacol.,1990

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal Sympathetic Hyperactivity in Diabetes Is Modulated by 5-HT1D Receptor Activation via NO Pathway;International Journal of Molecular Sciences;2023-01-10

2. Serotonergic modulation of neuronal activity in rat midbrain periaqueductal gray;Journal of Neurophysiology;2013-06-01

3. Serotonin modulates glutamatergic transmission in the rat olfactory tubercle;European Journal of Neuroscience;2010-02

4. Peripheral 5-HT1Aand 5-HT7Serotonergic Receptors Modulate Parasympathetic Neurotransmission in Long-Term Diabetic Rats;Experimental Diabetes Research;2010

5. Migraine in the triptan era: progresses achieved, lessons learned and future developments;Arquivos de Neuro-Psiquiatria;2009-06